Leadership Team

The Leadership Team at Immunomic Therapeutics is responsible for setting the strategic direction and overseeing the execution of the company's clinical programs and business initiatives. This team, comprising key executives like the CFO and Chief Scientific Officer, ensures regulatory compliance, drives scientific innovation, and manages financial health to advance the development of the UNITE nucleic acid immunotherapy platform. Their collaborative efforts aim to propel the company towards successful clinical outcomes and sustainable growth in the biotechnology sector.